cagrisema semaglutide Did Not Meet Primary End Point of Noninferiority to Tirzepatide Efficacy and safety of co-administered

For younger employees who grew up with greater flexibility as an expectation rather than a perk, PTO policies, remote work options, and holiday calendars are not peripheral considerations

consequently, the inhibition of these side-effects by GIPR agonism is critical

22% reported vomiting, compared to 4% of placebo 31% reported dizziness, compared to 6% of placebo 12% reported heart palpitations, compared to 2% of placebo

While shortages of certain formulations of Adderall have been resolved, other formulations remain in shortage, according to the FDA

What the clinical trial evidence shows Mounjaro (tirzepatide) ~22.5% average body weight lost at 72 weeks ( SURMOUNT-1, 15mg) Wegovy (semaglutide) ~14.9% average body weight lost at 68 weeks ( STEP-1 , 2.4mg) Saxenda / Nevolat (liraglutide) ~5-8% average body weight lost at 56 weeks ( SCALE trial ) For context, prior to GLP-1 medications, the most effective non-surgical weight loss intervention available was a combination of intensive lifestyle modification and Orlistat , which typically produces 5 to 8% weight loss

Pricing pages show from $199/mo with 12month prepay for injectables, and terms state you must cancel 2 days before renewal